What Does a Lysosome Do? Function and Enzymes

By Dr. Zubair Khalid, DVM, MS, PhD ·

What Does a Lysosome Do? Function and Enzymes

A lysosome is a membrane-bound organelle that maintains an acidic interior of roughly pH 4.5 to 5.0 and houses more than 60 acid hydrolases that break down proteins, lipids, nucleic acids, carbohydrates, and worn-out organelles. In one sentence, what does a lysosome do? It serves as the cell's recycling and digestion center, receiving material from outside the cell and from its own interior, degrading that material into reusable building blocks, and feeding the results back into metabolism.

That definition matters because the lysosome is not a passive trash bin. It sits at the intersection of nutrient sensing, membrane repair, immunity, and cell death. When a single lysosomal enzyme fails, its substrate accumulates and produces one of more than 70 inherited metabolic disorders known collectively as lysosomal storage diseases [1]. Those disorders range from blood and bone disease to severe neurodegeneration, which is why the lysosome occupies a central place in cell biology, neurology, and pediatrics.

Lysosome Structure and the Acidic Interior

A lysosome is bounded by a single phospholipid bilayer, roughly 0.5 micrometers across in most mammalian cells, though size varies with cargo load. The membrane is not a simple bag. It carries embedded proteins that import substrates, export digestion products, and fuse with other vesicles.

The defining chemical feature is acidity. The interior sits near pH 4.5 to 5.0, while the surrounding cytosol is near pH 7.2. This gradient is generated and maintained by a vacuolar-type H+-ATPase, usually written v-ATPase, a proton pump that hydrolyzes ATP to move protons into the lumen. The acidic environment is not incidental. Acid hydrolases are designed to work optimally at low pH, and most of them are largely inactive at cytosolic pH. This is a safety feature. If a lysosomal enzyme leaks into the cytosol, it does very little damage because its catalytic residues are tuned to an environment that no longer exists.

The membrane also protects the cell from its own enzymes. Lysosomal membrane proteins, including the heavily glycosylated LAMP1 and LAMP2, form a glycocalyx on the inner face that shields the lipid bilayer from hydrolysis. When this barrier fails, cathepsins escape into the cytosol and can trigger apoptosis.

How enzymes reach the lysosome

Lysosomal enzymes are synthesized on ribosomes bound to the endoplasmic reticulum, then glycosylated and tagged with mannose-6-phosphate in the Golgi. Mannose-6-phosphate receptors capture the tagged enzymes and route them into clathrin-coated vesicles destined for the endolysosomal system. Sorting at the Golgi is well characterized, but export of these enzymes from the endoplasmic reticulum is also regulated. One study showed that de novo lipogenesis controls this step, because fatty acids produced by that pathway are used to myristoylate the small GTPase Arf1, and myristoylated Arf1 sustains the retrograde Golgi-to-ER traffic needed for efficient enzyme export [2]. Deficiencies anywhere in this pipeline produce lysosomal storage disease, which is why the trafficking machinery is studied as intensively as the enzymes themselves.

A quick comparison with related organelles

OrganelleDefining featureMain jobTypical pH
LysosomeAcid hydrolases, v-ATPaseDegradation and recycling4.5 to 5.0
PeroxisomeOxidases and catalaseFatty acid oxidation, reactive oxygen handlingNear neutral
ProteasomeBarrel-shaped protease complexATP-dependent protein degradationCytosolic
EndosomeSorting platform, matures into lysosomeCargo sorting and deliveryDrops from neutral to acidic
AutophagosomeDouble membrane, forms de novoDelivers cytoplasmic cargo to lysosomesCytosolic until fusion

The lysosome is most often confused with the proteasome. The proteasome degrades individual ubiquitin-tagged proteins in the cytosol. The lysosome degrades whole organelles, bulk protein, lipids, and material captured from outside the cell.

The Three Degradation Routes

Material reaches the lysosome by three main routes. Each one uses a different entry mechanism, and each one matters for a different set of diseases.

Endocytosis

Endocytosis captures extracellular fluid and membrane-bound cargo. The plasma membrane invaginates to form a vesicle, which matures into an early endosome, then a late endosome, and finally fuses with a lysosome. Receptor-mediated endocytosis is the selective version. Cells use it to take up low-density lipoprotein, transferrin, and many signaling receptors that need to be switched off. The lysosome-targeted fluorescent probes used in research rely partly on this pathway, since ligand conjugates and nanoparticles enter cells through receptor-mediated endocytosis or passive endocytic accumulation [3].

Phagocytosis

Phagocytosis is the uptake of large particles, typically microbes or cell debris. It is restricted mainly to professional phagocytes such as macrophages and neutrophils. The particle is engulfed into a phagosome, which fuses with lysosomes to form a phagolysosome. Acidification of that compartment is what kills most ingested bacteria, and cathepsins complete the digestion.

Pathogens have evolved ways to break this system. African swine fever virus infects porcine alveolar macrophages and, despite increasing phagocytic uptake, cripples bacterial killing by disrupting phagolysosomal acidification and structural integrity, which allows ingested bacteria to survive intracellularly [4]. That example shows why acidification is not a detail. It is the functional core of the phagocytic killing mechanism.

Autophagy

Autophagy means self-eating. A double-membrane structure called an autophagosome forms in the cytosol, engulfs damaged organelles, protein aggregates, or bulk cytoplasm, and then fuses with a lysosome. The resulting autolysosome degrades the contents. Autophagy is the cell's main route for clearing mitochondria, misfolded protein aggregates, and intracellular pathogens.

Autophagy is tightly regulated by transcription factors, notably TFEB, which drives expression of lysosomal and autophagic genes. Mesenchymal stromal cells exert part of their protective effect in neurodegenerative and lysosomal storage disease models through TFEB-mediated autophagy regulation and enzymatic cross-correction [5]. Cross-correction means that a donor cell secretes a functional enzyme that neighboring enzyme-deficient cells can take up through mannose-6-phosphate receptors, restoring their lysosomal function.

How the Main Routes Converge

The flowchart below traces the decision path from cargo type to degradation.

flowchart TD
    A[Cargo appears] --> B{Where is the cargo}
    B --> C[Outside the cell]
    B --> D[Inside the cytosol]
    C --> E{Size of particle}
    E --> F[Small or fluid phase]
    E --> G[Large particle]
    F --> H[Endocytosis]
    G --> I[Phagocytosis]
    D --> J[Autophagy]
    H --> K[Endosome]
    I --> L[Phagosome]
    J --> M[Autophagosome]
    K --> N[Lysosome fusion]
    L --> N
    M --> N
    N --> O[Acid hydrolase digestion]
    O --> P[Export of building blocks]

What the Lysosome Does Beyond Digestion

Degradation is the headline function, but the lysosome does more.

Nutrient sensing through mTORC1

The lysosome is the platform on which mTORC1, a central growth-regulating kinase, is activated. When amino acids are plentiful, they are sensed at the lysosomal surface, and mTORC1 signals that the cell should build rather than recycle. When amino acids are scarce, mTORC1 is inhibited, and autophagy increases to generate internal nutrients. This places the lysosome at the top of the cell's nutrient decision tree. Lysosomal dysfunction therefore distorts growth signaling, not just waste disposal.

Membrane repair and exocytosis

Lysosomes can fuse with the plasma membrane and release their contents outside the cell, a process called lysosomal exocytosis. In the retinal pigment epithelium, age-related loss of the lipid elongase ELOVL2 alters membrane lipid composition and triggers a lysosome-dependent plasma membrane repair program. That adaptive response preserves barrier function but also drives polarized lysosomal exocytosis and accumulation of deposits associated with aging and age-related macular degeneration [6]. The same repair machinery that protects the cell can contribute to disease when it runs chronically.

Immune signaling

Lysosomal proteases shape innate immunity. Cathepsin L stabilizes STING, the adaptor that drives type I interferon production in response to cytosolic DNA, by blocking AP1B1-mediated lysosomal degradation of STING. Cathepsin L deficiency selectively impairs STING-induced interferon responses without disrupting general lysosomal digestion, and cathepsin L levels are elevated in cells from patients with systemic lupus erythematosus [7]. This shows that a single lysosomal protease can tune an immune pathway independently of bulk degradative capacity.

Lysosomal Storage Diseases: Enzyme Defects and Accumulated Substrates

Lysosomal storage diseases are inherited disorders in which a specific hydrolase or transport protein is defective, so its substrate accumulates inside the lysosome. More than 70 such disorders are recognized, and they are classified by the biochemical nature of the stored material, which reflects both the enzyme defect and the clinical phenotype [1]. The table below links four classic examples to their defective enzyme and stored substrate.

DiseaseDefective enzymeAccumulated substrateNotes
Tay-Sachs diseaseHexosaminidase AGM2 gangliosideA gangliosidosis with severe neurodevelopmental impact [1]
Gaucher diseaseGlucocerebrosidaseGlucocerebrosideMost common lysosomal storage disorder, causes cytopenias and splenomegaly [8]
Pompe diseaseAcid alpha-glucosidaseGlycogenListed among the lipid and glycogen storage disorders [1]
Niemann-Pick diseaseSphingomyelinaseSphingomyelinSphingolipidosis with neurologic and visceral involvement [1]

Two additional examples show how broad the category is. Fabry disease results from deficient alpha-galactosidase A activity and progressive accumulation of globotriaosylceramide and globotriaosylsphingosine, and its progression involves chronic inflammation, oxidative stress, endothelial dysfunction, and impaired autophagy alongside the primary storage defect [9]. Cystinosis is caused by pathogenic variants in CTNS and leads to cystine accumulation in all organs, with renal Fanconi syndrome appearing around 6 to 12 months of age [10].

Why substrate accumulation is toxic

Accumulated substrate is not inert. It changes membrane composition, distorts vesicle trafficking, and activates inflammatory and stress responses. In Gaucher disease, altered red blood cell mechanics contribute to vascular occlusion, bone infarcts, and splenomegaly, with splenic slit passage times rising from about 250 milliseconds in control cells to more than 1200 milliseconds in a severe subtype [11]. In Fabry disease, the storage material is only the starting point, and downstream inflammation and autophagy impairment drive much of the organ damage [9].

Diagnosis in practice

Diagnosis typically combines enzyme activity assays, biomarker measurement, and genetic testing. In a reported case of type 1 Gaucher disease, a patient had splenomegaly from infancy and persistent cytopenias through childhood, but the diagnosis was not made until age 15, when enzymatic testing, biomarker assessment, and genetic analysis confirmed it [8]. That delay is common because early signs are nonspecific. Broader sequencing has shifted the picture in the other direction for some disorders. When the GLA gene was added to broader next-generation sequencing and whole-exome panels, more individuals with milder GLA variants were identified, and for many of them cardiomyopathy was the presenting and only symptom rather than the classic multisystem Fabry phenotype [12]. Genetic heterogeneity is substantial, with 64 different GLA variants identified in a cohort of 319 patients [12].

Lysosomal Dysfunction in Neurodegeneration and Aging

Neurons are especially vulnerable to lysosomal failure. They are postmitotic, so they cannot dilute accumulated waste by dividing, and their long axons depend on efficient retrograde transport of damaged material to the cell body for degradation.

The evidence linking lysosomes to neurodegeneration is now broad. Leucine-rich repeat kinase 2, or LRRK2, is a central node connecting genetic risk, membrane trafficking, lysosomal homeostasis, and immune signaling in Parkinson's disease. Pathogenic mutations and lysosomal stress reshape the conformational landscape of LRRK2 and alter its phosphorylation of Rab GTPases such as Rab8 and Rab10, with disproportionate effects on vesicle trafficking, autophagy, and organelle positioning [13]. Batten disease illustrates the lipid side of the same problem. The CLN8 protein is a stereospecific acyltransferase that works with the lysosomal enzyme CLN5 to produce bis(monoacylglycero)phosphate, a signature lysosomal phospholipid. Batten disease mutations impair CLN8 activity and abolish bis(monoacylglycero)phosphate production, and supplying the correct stereoisomer of the precursor restores synthesis and improves neurological phenotypes in model systems [14]. A companion study describes this as a non-canonical phospholipid synthesis pathway whose loss causes phospholipid accumulation in lysosomes [15].

Aging intersects with lysosomes on several fronts. Epigenetic clock analyses in Fabry disease patients have been used to explore biological aging, though the methylation differences between variant carriers did not survive correction for multiple testing in that exploratory cohort [16]. The retinal aging work described earlier shows a cleaner mechanistic link, where age-dependent membrane lipid remodeling engages a lysosomal repair program that leaves behind deposits characteristic of age-related macular degeneration [6]. Together these findings support the view that lysosomal capacity declines with age and that this decline feeds back into tissue degeneration.

Common Mistakes and Limitations

Treating the lysosome as a static organelle. Lysosomal number, size, pH, and enzyme content change with nutrient status, stress, and cell type. A single snapshot does not describe the system.

Confusing the lysosome with the proteasome. The proteasome handles ubiquitin-tagged individual proteins in the cytosol. The lysosome handles bulk cargo, organelles, and material from outside the cell.

Assuming all lysosomal enzymes work at neutral pH. Acid hydrolases are optimized for pH 4.5 to 5.0. Assays run at the wrong pH will underestimate activity.

Ignoring the trafficking pathway. A normal enzyme coding sequence does not guarantee normal function. Defects in mannose-6-phosphate tagging, receptor sorting, or ER export produce storage disease even when the enzyme itself is catalytically intact [2].

Overreading a single enzyme result. Enzyme activity varies by tissue, age, and assay conditions. Confirmation usually requires a second modality such as genetic testing or biomarker measurement.

Expecting one mechanism per disease. Fabry disease involves storage, inflammation, oxidative stress, endothelial dysfunction, and impaired autophagy at the same time [9]. Batten disease involves both a lipid synthesis defect and downstream cargo accumulation [14][15].

Individual cases require veterinary or medical evaluation. The general principles here describe the biology, not a diagnostic algorithm for a specific patient.

Quick Review

  • A lysosome is an acidic, membrane-bound organelle with a lumen near pH 4.5 to 5.0, maintained by the v-ATPase proton pump.
  • It contains more than 60 acid hydrolases that degrade proteins, lipids, nucleic acids, and carbohydrates.
  • Three routes deliver cargo: endocytosis, phagocytosis, and autophagy. All converge on lysosomal fusion and acid hydrolysis.
  • The lysosome is a signaling hub. It activates mTORC1 for nutrient sensing, supports membrane repair through exocytosis, and shapes immune signaling through proteases such as cathepsin L.
  • Lysosomal storage diseases result from defective enzymes or transport proteins. More than 70 are recognized and classified by stored substrate [1].
  • Tay-Sachs, Gaucher, Pompe, and Niemann-Pick map to hexosaminidase A, glucocerebrosidase, acid alpha-glucosidase, and sphingomyelinase respectively.
  • Lysosomal dysfunction contributes to neurodegeneration through pathways including LRRK2 and Rab GTPase signaling [13] and to aging through membrane lipid remodeling and repair programs [6].

Frequently Asked Questions

What does a lysosome do in a cell?

It digests macromolecules and worn-out organelles using acid hydrolases, recycles the breakdown products, and serves as a signaling platform for nutrient sensing and immunity.

What is the pH inside a lysosome and why does it matter?

The interior sits near pH 4.5 to 5.0, maintained by the v-ATPase proton pump. Acid hydrolases require this low pH for optimal activity and are largely inactive if they leak into the neutral cytosol.

What are the three main ways material enters a lysosome?

Endocytosis brings in extracellular fluid and receptor-bound cargo, phagocytosis engulfs large particles such as microbes, and autophagy delivers cytoplasmic material and damaged organelles.

Which enzymes are defective in Tay-Sachs, Gaucher, Pompe, and Niemann-Pick disease?

Tay-Sachs involves hexosaminidase A with GM2 ganglioside accumulation, Gaucher involves glucocerebrosidase with glucocerebroside accumulation, Pompe involves acid alpha-glucosidase with glycogen accumulation, and Niemann-Pick involves sphingomyelinase with sphingomyelin accumulation.

How does the lysosome connect to mTORC1?

The lysosomal surface is where mTORC1 is activated in response to amino acid availability. When amino acids are scarce, mTORC1 is inhibited and autophagy increases to supply internal nutrients.

Why are neurons so sensitive to lysosomal dysfunction?

Neurons do not divide, so they cannot dilute accumulated waste, and their long axons depend on efficient transport of damaged material back to the cell body for lysosomal degradation.

Related Articles

Sources

  1. Disruptions in speech, language and social communication in lysosomal storage diseases.
  2. Lipids regulate export of lysosomal enzymes from the endoplasmic reticulum.
  3. Functional lysosomal probes from pH sensing and enzyme activation to targeted nanoplatforms.
  4. African swine fever virus impairs porcine alveolar macrophages bactericidal function by disrupting lysosomal acidification and cathepsin activity.
  5. Application of Mesenchymal Stromal Cells and Their Exosomes in Neurodegenerative Diseases and Lysosomal Storage Diseases.
  6. Lipid-driven membrane remodeling engages a lysosome-dependent adaptive repair program during retinal aging.
  7. Cathepsin L potentiates autoimmunity by inhibiting lysosome-mediated STING degradation.
  8. Delayed Diagnosis of Type 1 Gaucher Disease at Age 15 After Years of Mild Cytopenias and Splenomegaly: A Case Report and Long-Term Follow-Up.
  9. Fabry Disease: Integrating Molecular Pathophysiology, Precision Diagnosis, and Artificial Intelligence Toward Precision Medicine.
  10. Cystinosis-associated metabolic bone disease: pathogenesis and outcome.
  11. Quantifying the Biophysical Properties of Red Blood Cells in Gaucher Disease.
  12. The changing landscape of Fabry disease: Impact of the inclusion of the GLA-gene in broader NGS or WES based panels on the phenotypic spectrum.
  13. LRRK2: Molecular Mechanisms in Parkinson's Disease.
  14. The Batten disease protein CLN8 is a stereospecific acyltransferase in bis(monoacylglycero)phosphate biosynthesis.
  15. Batten disease protein CLN8 enables a non-canonical phospholipid synthesis pathway.
  16. Epigenetic aging and autosomal methylation remodeling in Anderson-Fabry disease.